New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> WHO Recommends Three Shorter, Oral Treatments for Drug-Resistant TB 22/08/2024 Kerry Cullinan The World Health Organization (WHO) this week recommended three new regimens for multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) tuberculosis (TB) that are far shorter than the current regimens and can be taken orally. The new regimens can cure patients in six to nine months rather than the usual 18 months and dispense with the painful injections […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Nigeria’s Primary Health Centers Are Essential for NCD Control – But Lack Drugs and Support 26/07/2024 Kate Okorie Fifteen-year-old Mathias Ofoke is one of four children in his family born with type 1 diabetes. Whenever his symptoms worsened, he was taken to the nearest primary healthcare (PHC) center where he was repeatedly treated for malaria. It wasn’t until February, when a non-governmental organization (NGO), Abby Cares Foundation, organized a clinical outreach at Ezza […] Continue reading -> Germany Pledges Continued Global AIDS Support Amid Fiscal and Political Pressures 23/07/2024 Kerry Cullinan MUNICH – German Chancellor Olaf Scholz reaffirmed his government’s commitment to the global campaign against AIDS, including the Global Fund, at the opening of the international AIDS Conference – and appealed to other global powers to do the same. The Ukraine war is draining Germany’s resources, and on the far right, the substantial and growing […] Continue reading -> UNAIDS Blames Punitive Laws and Stigma for HIV Surge in Eastern Europe and Central Asia 22/07/2024 Kerry Cullinan MUNICH – While new HIV infections in 2023 plummeted globally to the level that they were in the late 1980s, they have surged by 20% in Eastern Europe and Central Asia since 2010, according to UNAIDS. There were 140,000 new HIV infections across Eastern Europe and Central Asia in 2023, with 93% of new cases […] Continue reading -> By 2035, Most People Living With HIV Will Also Have a Chronic Disease 17/07/2024 Katie Dain & Cynthia Cardona By 2035, nearly three quarters of the 40 million people living with HIV worldwide will be living with one or more chronic disease, also referred to as noncommunicable diseases (NCDs). While there are encouraging examples of integrated HIV and NCD healthcare delivery, this is yet to become the norm in low- and middle-income countries. As stakeholders […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Posts navigation Older postsNewer posts
Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> WHO Recommends Three Shorter, Oral Treatments for Drug-Resistant TB 22/08/2024 Kerry Cullinan The World Health Organization (WHO) this week recommended three new regimens for multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) tuberculosis (TB) that are far shorter than the current regimens and can be taken orally. The new regimens can cure patients in six to nine months rather than the usual 18 months and dispense with the painful injections […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Nigeria’s Primary Health Centers Are Essential for NCD Control – But Lack Drugs and Support 26/07/2024 Kate Okorie Fifteen-year-old Mathias Ofoke is one of four children in his family born with type 1 diabetes. Whenever his symptoms worsened, he was taken to the nearest primary healthcare (PHC) center where he was repeatedly treated for malaria. It wasn’t until February, when a non-governmental organization (NGO), Abby Cares Foundation, organized a clinical outreach at Ezza […] Continue reading -> Germany Pledges Continued Global AIDS Support Amid Fiscal and Political Pressures 23/07/2024 Kerry Cullinan MUNICH – German Chancellor Olaf Scholz reaffirmed his government’s commitment to the global campaign against AIDS, including the Global Fund, at the opening of the international AIDS Conference – and appealed to other global powers to do the same. The Ukraine war is draining Germany’s resources, and on the far right, the substantial and growing […] Continue reading -> UNAIDS Blames Punitive Laws and Stigma for HIV Surge in Eastern Europe and Central Asia 22/07/2024 Kerry Cullinan MUNICH – While new HIV infections in 2023 plummeted globally to the level that they were in the late 1980s, they have surged by 20% in Eastern Europe and Central Asia since 2010, according to UNAIDS. There were 140,000 new HIV infections across Eastern Europe and Central Asia in 2023, with 93% of new cases […] Continue reading -> By 2035, Most People Living With HIV Will Also Have a Chronic Disease 17/07/2024 Katie Dain & Cynthia Cardona By 2035, nearly three quarters of the 40 million people living with HIV worldwide will be living with one or more chronic disease, also referred to as noncommunicable diseases (NCDs). While there are encouraging examples of integrated HIV and NCD healthcare delivery, this is yet to become the norm in low- and middle-income countries. As stakeholders […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Posts navigation Older postsNewer posts
How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> WHO Recommends Three Shorter, Oral Treatments for Drug-Resistant TB 22/08/2024 Kerry Cullinan The World Health Organization (WHO) this week recommended three new regimens for multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) tuberculosis (TB) that are far shorter than the current regimens and can be taken orally. The new regimens can cure patients in six to nine months rather than the usual 18 months and dispense with the painful injections […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Nigeria’s Primary Health Centers Are Essential for NCD Control – But Lack Drugs and Support 26/07/2024 Kate Okorie Fifteen-year-old Mathias Ofoke is one of four children in his family born with type 1 diabetes. Whenever his symptoms worsened, he was taken to the nearest primary healthcare (PHC) center where he was repeatedly treated for malaria. It wasn’t until February, when a non-governmental organization (NGO), Abby Cares Foundation, organized a clinical outreach at Ezza […] Continue reading -> Germany Pledges Continued Global AIDS Support Amid Fiscal and Political Pressures 23/07/2024 Kerry Cullinan MUNICH – German Chancellor Olaf Scholz reaffirmed his government’s commitment to the global campaign against AIDS, including the Global Fund, at the opening of the international AIDS Conference – and appealed to other global powers to do the same. The Ukraine war is draining Germany’s resources, and on the far right, the substantial and growing […] Continue reading -> UNAIDS Blames Punitive Laws and Stigma for HIV Surge in Eastern Europe and Central Asia 22/07/2024 Kerry Cullinan MUNICH – While new HIV infections in 2023 plummeted globally to the level that they were in the late 1980s, they have surged by 20% in Eastern Europe and Central Asia since 2010, according to UNAIDS. There were 140,000 new HIV infections across Eastern Europe and Central Asia in 2023, with 93% of new cases […] Continue reading -> By 2035, Most People Living With HIV Will Also Have a Chronic Disease 17/07/2024 Katie Dain & Cynthia Cardona By 2035, nearly three quarters of the 40 million people living with HIV worldwide will be living with one or more chronic disease, also referred to as noncommunicable diseases (NCDs). While there are encouraging examples of integrated HIV and NCD healthcare delivery, this is yet to become the norm in low- and middle-income countries. As stakeholders […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Posts navigation Older postsNewer posts
WHO Recommends Three Shorter, Oral Treatments for Drug-Resistant TB 22/08/2024 Kerry Cullinan The World Health Organization (WHO) this week recommended three new regimens for multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) tuberculosis (TB) that are far shorter than the current regimens and can be taken orally. The new regimens can cure patients in six to nine months rather than the usual 18 months and dispense with the painful injections […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Nigeria’s Primary Health Centers Are Essential for NCD Control – But Lack Drugs and Support 26/07/2024 Kate Okorie Fifteen-year-old Mathias Ofoke is one of four children in his family born with type 1 diabetes. Whenever his symptoms worsened, he was taken to the nearest primary healthcare (PHC) center where he was repeatedly treated for malaria. It wasn’t until February, when a non-governmental organization (NGO), Abby Cares Foundation, organized a clinical outreach at Ezza […] Continue reading -> Germany Pledges Continued Global AIDS Support Amid Fiscal and Political Pressures 23/07/2024 Kerry Cullinan MUNICH – German Chancellor Olaf Scholz reaffirmed his government’s commitment to the global campaign against AIDS, including the Global Fund, at the opening of the international AIDS Conference – and appealed to other global powers to do the same. The Ukraine war is draining Germany’s resources, and on the far right, the substantial and growing […] Continue reading -> UNAIDS Blames Punitive Laws and Stigma for HIV Surge in Eastern Europe and Central Asia 22/07/2024 Kerry Cullinan MUNICH – While new HIV infections in 2023 plummeted globally to the level that they were in the late 1980s, they have surged by 20% in Eastern Europe and Central Asia since 2010, according to UNAIDS. There were 140,000 new HIV infections across Eastern Europe and Central Asia in 2023, with 93% of new cases […] Continue reading -> By 2035, Most People Living With HIV Will Also Have a Chronic Disease 17/07/2024 Katie Dain & Cynthia Cardona By 2035, nearly three quarters of the 40 million people living with HIV worldwide will be living with one or more chronic disease, also referred to as noncommunicable diseases (NCDs). While there are encouraging examples of integrated HIV and NCD healthcare delivery, this is yet to become the norm in low- and middle-income countries. As stakeholders […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Posts navigation Older postsNewer posts
Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Nigeria’s Primary Health Centers Are Essential for NCD Control – But Lack Drugs and Support 26/07/2024 Kate Okorie Fifteen-year-old Mathias Ofoke is one of four children in his family born with type 1 diabetes. Whenever his symptoms worsened, he was taken to the nearest primary healthcare (PHC) center where he was repeatedly treated for malaria. It wasn’t until February, when a non-governmental organization (NGO), Abby Cares Foundation, organized a clinical outreach at Ezza […] Continue reading -> Germany Pledges Continued Global AIDS Support Amid Fiscal and Political Pressures 23/07/2024 Kerry Cullinan MUNICH – German Chancellor Olaf Scholz reaffirmed his government’s commitment to the global campaign against AIDS, including the Global Fund, at the opening of the international AIDS Conference – and appealed to other global powers to do the same. The Ukraine war is draining Germany’s resources, and on the far right, the substantial and growing […] Continue reading -> UNAIDS Blames Punitive Laws and Stigma for HIV Surge in Eastern Europe and Central Asia 22/07/2024 Kerry Cullinan MUNICH – While new HIV infections in 2023 plummeted globally to the level that they were in the late 1980s, they have surged by 20% in Eastern Europe and Central Asia since 2010, according to UNAIDS. There were 140,000 new HIV infections across Eastern Europe and Central Asia in 2023, with 93% of new cases […] Continue reading -> By 2035, Most People Living With HIV Will Also Have a Chronic Disease 17/07/2024 Katie Dain & Cynthia Cardona By 2035, nearly three quarters of the 40 million people living with HIV worldwide will be living with one or more chronic disease, also referred to as noncommunicable diseases (NCDs). While there are encouraging examples of integrated HIV and NCD healthcare delivery, this is yet to become the norm in low- and middle-income countries. As stakeholders […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Posts navigation Older postsNewer posts
Nigeria’s Primary Health Centers Are Essential for NCD Control – But Lack Drugs and Support 26/07/2024 Kate Okorie Fifteen-year-old Mathias Ofoke is one of four children in his family born with type 1 diabetes. Whenever his symptoms worsened, he was taken to the nearest primary healthcare (PHC) center where he was repeatedly treated for malaria. It wasn’t until February, when a non-governmental organization (NGO), Abby Cares Foundation, organized a clinical outreach at Ezza […] Continue reading -> Germany Pledges Continued Global AIDS Support Amid Fiscal and Political Pressures 23/07/2024 Kerry Cullinan MUNICH – German Chancellor Olaf Scholz reaffirmed his government’s commitment to the global campaign against AIDS, including the Global Fund, at the opening of the international AIDS Conference – and appealed to other global powers to do the same. The Ukraine war is draining Germany’s resources, and on the far right, the substantial and growing […] Continue reading -> UNAIDS Blames Punitive Laws and Stigma for HIV Surge in Eastern Europe and Central Asia 22/07/2024 Kerry Cullinan MUNICH – While new HIV infections in 2023 plummeted globally to the level that they were in the late 1980s, they have surged by 20% in Eastern Europe and Central Asia since 2010, according to UNAIDS. There were 140,000 new HIV infections across Eastern Europe and Central Asia in 2023, with 93% of new cases […] Continue reading -> By 2035, Most People Living With HIV Will Also Have a Chronic Disease 17/07/2024 Katie Dain & Cynthia Cardona By 2035, nearly three quarters of the 40 million people living with HIV worldwide will be living with one or more chronic disease, also referred to as noncommunicable diseases (NCDs). While there are encouraging examples of integrated HIV and NCD healthcare delivery, this is yet to become the norm in low- and middle-income countries. As stakeholders […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Posts navigation Older postsNewer posts
Germany Pledges Continued Global AIDS Support Amid Fiscal and Political Pressures 23/07/2024 Kerry Cullinan MUNICH – German Chancellor Olaf Scholz reaffirmed his government’s commitment to the global campaign against AIDS, including the Global Fund, at the opening of the international AIDS Conference – and appealed to other global powers to do the same. The Ukraine war is draining Germany’s resources, and on the far right, the substantial and growing […] Continue reading -> UNAIDS Blames Punitive Laws and Stigma for HIV Surge in Eastern Europe and Central Asia 22/07/2024 Kerry Cullinan MUNICH – While new HIV infections in 2023 plummeted globally to the level that they were in the late 1980s, they have surged by 20% in Eastern Europe and Central Asia since 2010, according to UNAIDS. There were 140,000 new HIV infections across Eastern Europe and Central Asia in 2023, with 93% of new cases […] Continue reading -> By 2035, Most People Living With HIV Will Also Have a Chronic Disease 17/07/2024 Katie Dain & Cynthia Cardona By 2035, nearly three quarters of the 40 million people living with HIV worldwide will be living with one or more chronic disease, also referred to as noncommunicable diseases (NCDs). While there are encouraging examples of integrated HIV and NCD healthcare delivery, this is yet to become the norm in low- and middle-income countries. As stakeholders […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Posts navigation Older postsNewer posts
UNAIDS Blames Punitive Laws and Stigma for HIV Surge in Eastern Europe and Central Asia 22/07/2024 Kerry Cullinan MUNICH – While new HIV infections in 2023 plummeted globally to the level that they were in the late 1980s, they have surged by 20% in Eastern Europe and Central Asia since 2010, according to UNAIDS. There were 140,000 new HIV infections across Eastern Europe and Central Asia in 2023, with 93% of new cases […] Continue reading -> By 2035, Most People Living With HIV Will Also Have a Chronic Disease 17/07/2024 Katie Dain & Cynthia Cardona By 2035, nearly three quarters of the 40 million people living with HIV worldwide will be living with one or more chronic disease, also referred to as noncommunicable diseases (NCDs). While there are encouraging examples of integrated HIV and NCD healthcare delivery, this is yet to become the norm in low- and middle-income countries. As stakeholders […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Posts navigation Older postsNewer posts
By 2035, Most People Living With HIV Will Also Have a Chronic Disease 17/07/2024 Katie Dain & Cynthia Cardona By 2035, nearly three quarters of the 40 million people living with HIV worldwide will be living with one or more chronic disease, also referred to as noncommunicable diseases (NCDs). While there are encouraging examples of integrated HIV and NCD healthcare delivery, this is yet to become the norm in low- and middle-income countries. As stakeholders […] Continue reading -> World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Posts navigation Older postsNewer posts
World’s Leading HIV Drug Reduces Carbon Emissions by 26 Million Tons In Comparison to Predecessor 15/07/2024 Disha Shetty The lifesaving HIV treatment dolutegravir (DTG), used by 24 million people in low-and middle-income countries (LMICs), has unexpectedly contributed to a significant reduction in carbon emissions when compared to the previous standard of care, efavirenz, according to the latest report by global health initiative Unitaid. The report estimates that the transition to DTG will have […] Continue reading -> Posts navigation Older postsNewer posts